Equifax (EFX) Competitors

In the previous week, Equifax had 12 more articles in the media than Aptiv. MarketBeat recorded 15 mentions for Equifax and 3 mentions for Aptiv. Aptiv's average media sentiment score of 0.19 beat Equifax's score of 0.02 indicating that Aptiv is being referred to more favorably in the news media.

Equifax has higher earnings, but lower revenue than Aptiv. Equifax is trading at a lower price-to-earnings ratio than Aptiv, indicating that it is currently the more affordable of the two stocks.

Equifax has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, Aptiv has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

96.2% of Equifax shares are held by institutional investors. Comparatively, 94.2% of Aptiv shares are held by institutional investors. 1.7% of Equifax shares are held by insiders. Comparatively, 0.1% of Aptiv shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Equifax has a net margin of 10.73% compared to Aptiv's net margin of 1.17%. Equifax's return on equity of 21.61% beat Aptiv's return on equity.

Equifax presently has a consensus target price of $206.90, suggesting a potential upside of 47.81%. Aptiv has a consensus target price of $73.60, suggesting a potential upside of 69.02%. Given Aptiv's higher possible upside, analysts clearly believe Aptiv is more favorable than Equifax.

Equifax currently has a consensus target price of $206.90, indicating a potential upside of 47.81%. Booz Allen Hamilton has a consensus target price of $83.69, indicating a potential upside of 24.38%. Given Equifax's stronger consensus rating and higher probable upside, equities research analysts clearly believe Equifax is more favorable than Booz Allen Hamilton.

In the previous week, Equifax had 8 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 15 mentions for Equifax and 7 mentions for Booz Allen Hamilton. Booz Allen Hamilton's average media sentiment score of 0.59 beat Equifax's score of 0.02 indicating that Booz Allen Hamilton is being referred to more favorably in the news media.

Equifax has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market.

Booz Allen Hamilton has higher revenue and earnings than Equifax. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.6%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.5%. Equifax pays out 39.4% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 37.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has increased its dividend for 1 consecutive years and Booz Allen Hamilton has increased its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax has a net margin of 10.73% compared to Booz Allen Hamilton's net margin of 7.01%. Booz Allen Hamilton's return on equity of 76.71% beat Equifax's return on equity.

96.2% of Equifax shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 1.7% of Equifax shares are held by insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Equifax has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

In the previous week, Equifax had 10 more articles in the media than Genpact. MarketBeat recorded 15 mentions for Equifax and 5 mentions for Genpact. Genpact's average media sentiment score of 0.66 beat Equifax's score of 0.02 indicating that Genpact is being referred to more favorably in the news media.

96.2% of Equifax shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 1.7% of Equifax shares are held by company insiders. Comparatively, 1.6% of Genpact shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Equifax has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, Genpact has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.6%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.3%. Equifax pays out 39.4% of its earnings in the form of a dividend. Genpact pays out 22.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has increased its dividend for 1 consecutive years and Genpact has increased its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax currently has a consensus target price of $206.90, suggesting a potential upside of 47.81%. Genpact has a consensus target price of $39.33, suggesting a potential upside of 18.13%. Given Equifax's stronger consensus rating and higher possible upside, analysts clearly believe Equifax is more favorable than Genpact.

Genpact has a net margin of 11.04% compared to Equifax's net margin of 10.73%. Genpact's return on equity of 23.34% beat Equifax's return on equity.

89.6% of IQVIA shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 1.7% of IQVIA shares are held by insiders. Comparatively, 1.7% of Equifax shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Equifax had 2 more articles in the media than IQVIA. MarketBeat recorded 15 mentions for Equifax and 13 mentions for IQVIA. IQVIA's average media sentiment score of 0.56 beat Equifax's score of 0.02 indicating that IQVIA is being referred to more favorably in the media.

IQVIA has higher revenue and earnings than Equifax. Equifax is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.

IQVIA presently has a consensus target price of $264.31, indicating a potential upside of 2.26%. Equifax has a consensus target price of $206.90, indicating a potential upside of 47.81%. Given Equifax's higher possible upside, analysts clearly believe Equifax is more favorable than IQVIA.

Equifax has a net margin of 10.73% compared to IQVIA's net margin of 8.10%. IQVIA's return on equity of 30.25% beat Equifax's return on equity.

IQVIA has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, Equifax has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.